Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Feb. 28, 2023
Balances, shares at Feb. 28, 2023
Issuance of common stock	$ 90			90
Issuance of common stock, shares	9,000,000
Retroactive application of recapitalization	$ 4,052	(4,052)
Retroactive application of recapitalization, shares	32,420,154
Balance at Mar. 15, 2023	$ 4,142	(4,052)		90
Balances, shares at Mar. 15, 2023	41,420,154
Net loss			(245,505)	(245,505)
Balance at Mar. 31, 2023	$ 4,142	(4,052)	(245,505)	(245,415)
Balances, shares at Mar. 31, 2023	41,420,154
Balance at Mar. 15, 2023	$ 4,142	(4,052)		90
Balances, shares at Mar. 15, 2023	41,420,154
Net loss			(2,828,585)	(2,828,585)
Balance at Sep. 30, 2023	$ 4,142	(4,052)	(2,828,585)	(2,828,495)
Balances, shares at Sep. 30, 2023	41,420,154
Balance at Mar. 31, 2023	$ 4,142	(4,052)	(245,505)	(245,415)
Balances, shares at Mar. 31, 2023	41,420,154
Net loss			(1,739,280)	(1,739,280)
Balance at Jun. 30, 2023	$ 4,142	(4,052)	(1,984,785)	(1,984,695)
Balances, shares at Jun. 30, 2023	41,420,154
Net loss			(843,800)	(843,800)
Balance at Sep. 30, 2023	$ 4,142	(4,052)	(2,828,585)	(2,828,495)
Balances, shares at Sep. 30, 2023	41,420,154
Balance at Nov. 30, 2023	$ 87	58,736	(3,793,585)	(3,734,762)
Balances, shares at Nov. 30, 2023	9,017,300
Retroactive application of recapitalization	$ 3,936	(3,936)
Retroactive application of recapitalization, shares	32,482,472
Balance at Dec. 31, 2023	$ 4,023	54,800	(3,793,585)	(3,734,762)
Balances, shares at Dec. 31, 2023	41,499,772
Net loss			(1,399,213)	(1,399,213)
Stock based compensation (Note 3)		59,599		59,599
Transfer from early exercised stock option liability on vesting (Note 3)		100		100
Balance at Mar. 31, 2024	$ 4,023	114,499	(5,192,798)	(5,074,276)
Balances, shares at Mar. 31, 2024	41,499,772
Balance at Dec. 31, 2023	$ 4,023	54,800	(3,793,585)	(3,734,762)
Balances, shares at Dec. 31, 2023	41,499,772
Net loss			(14,185,887)	(14,185,887)
Stock based compensation (Note 3)		7,034,079		7,034,079
Transfer from early exercised stock option liability on vesting (Note 3)	12	971		983
Shares issued upon conversion of convertible notes	$ 26	2,571,374		2,571,400
Shares issued upon conversion of convertible notes, shares	257,216
Issuance of common stock upon the reverse capitalization including PIPE financing, net of transaction cost	$ 435	(5,483,454)		(5,483,019)
Issuance of common stock upon the reverse capitalization including PIPE financing, net of transaction cost, shares	5,342,745
Shares issued upon exercise of common stock warrants	$ 13	1,626,606		1,626,619
Shares issued upon exercise of common stock warrants, shares	135,796
Transaction costs		(7,501,223)		(7,501,223)
Merger Earnout shares (Note 3)		25,071,500	(25,071,500)
Shares issued upon conversion of SAFE notes	$ 64	6,367,136		6,367,200
Shares issued upon conversion of SAFE notes, shares	636,916
Balance at Sep. 30, 2024	$ 4,573	29,741,789	(43,050,972)	(13,304,610)
Balances, shares at Sep. 30, 2024	47,872,445
Balance at Mar. 31, 2024	$ 4,023	114,499	(5,192,798)	(5,074,276)
Balances, shares at Mar. 31, 2024	41,499,772
Net loss			(2,694,362)	(2,694,362)
Stock based compensation (Note 3)		58,125		58,125
Transfer from early exercised stock option liability on vesting (Note 3)		100		100
Balance at Jun. 30, 2024	$ 4,023	172,724	(7,887,160)	(7,710,413)
Balances, shares at Jun. 30, 2024	41,499,772
Net loss			(10,092,312)	(10,092,312)
Stock based compensation (Note 3)		6,916,355		6,916,355
Transfer from early exercised stock option liability on vesting (Note 3)	12	771		783
Shares issued upon conversion of SAFE notes	$ 64	6,367,136		6,367,200
Shares issued upon conversion of SAFE notes, shares	636,916
Shares issued upon conversion of convertible notes	$ 26	2,571,374		2,571,400
Shares issued upon conversion of convertible notes, shares	257,216
Issuance of common stock upon the reverse capitalization including PIPE financing, net of transaction cost	$ 435	(5,483,454)		(5,483,019)
Issuance of common stock upon the reverse capitalization including PIPE financing, net of transaction cost, shares	5,342,745
Shares issued upon exercise of common stock warrants	$ 13	1,626,606		1,626,619
Shares issued upon exercise of common stock warrants, shares	135,796
Transaction costs		(7,501,223)		(7,501,223)
Merger Earnout shares (Note 3)		25,071,500	(25,071,500)
Balance at Sep. 30, 2024	$ 4,573	$ 29,741,789	$ (43,050,972)	$ (13,304,610)
Balances, shares at Sep. 30, 2024	47,872,445